Aurora Cannabis, Inc.
Aurora Cannabis, Inc. (ACB) Accused of Failing to Disclose Sizable Impairment Charges During the relevant period, Aurora Cannabis, Inc. failed to disclose that it had significantly overpaid for recently
Aurora Cannabis, Inc. (ACB) Accused of Failing to Disclose Sizable Impairment Charges During the relevant period, Aurora Cannabis, Inc. failed to disclose that it had significantly overpaid for recently
Peabody Energy Corporation (BTU) Accused of Misleading Shareholders On April 3, 2017, Peabody emerged from bankruptcy, reporting record production for the North Goonyella mine and claiming it had achieved
Golar LNG Limited (GLNG) Accused of Misleading Shareholders On September 17, 2020, Golar announced the initial public offering of Hygo Energy Transition Ltd. (“Hygo”), a joint venture between Golar
NextCure, Inc. (NXTC) Accused of Misleading Shareholders During the class period, defendants misled investors regarding the efficacy of and objective responses observed in patients treated with NC318 from the
Eastman Kodak Co. (KODK) is Accused of Misleading Shareholders On July 27, 2020, Kodak granted its CEO and Executive Chairman 1.75 million stock options, and 45,000 options each to
Nikola Corporation (NKLA) Accused of Misleading Shareholders During the class period, Trevor Milton, chairman and founder, repeatedly falsely touted the strength of Nikola’s financial, technological, and operational profile. On September
GoHealth (GOCO) Accused of Misleading Shareholders In September 2019, private equity firm Centerbridge acquired GoHealth for $1.1 billion in equity and cash. According to the complaint, GoHealth reported tremendous growth
Nikola Corporation (NKLA) Accused of Misleading Shareholders During the class period, Trevor Milton, chairman and founder, repeatedly falsely touted the strength of Nikola’s financial, technological, and operational profile. On September
Odonate Therapeutics, Inc. (ODT) Accused of Misrepresenting Potential of New Cancer Drug During the relevant period, Odonate Therapeutics, Inc. touted the extent of its clinical trials of tesetaxel and the
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Stock Watch members receive free investment monitoring and notifications.